Merck to buy drug developer Pandion Therapeutics for $1.85 bln

Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%. Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

Reuters | Updated: 25-02-2021 18:14 IST | Created: 25-02-2021 18:09 IST
Merck to buy drug developer Pandion Therapeutics for $1.85 bln
Representative image. Image Credit: Wikimedia

Merck & Co Inc said on Thursday it would buy drug developer Pandion Therapeutics Inc for about $1.85 billion in cash, expanding its portfolio of drugs that target autoimmune diseases.

The $60-per-share deal represents about 134% premium to Pandion's closing price on Wednesday. Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%.

Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. In November, Merck agreed to buy privately-held VelosBio for $2.75 billion to strengthen its cancer drug portfolio as the drugmaker looks to reduce its reliance on its blockbuster cancer therapy Keytruda.

The deal between Merck and Pandion is expected to close in the first half of 2021, the companies said in a joint statement. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

East African women traders: 'Celebrating the past, planning for the future'

COVID-19 has hit women disproportionately hard across East Africa, especially those working in the informal sector. Lessons must be learnt to prevent this from happening again....

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

Videos

Latest News

Japan says to seek 'short, powerful' state of emergency for Tokyo, elsewhere

The Japanese government is seeking a short and powerful state of emergency for Tokyo, Osaka and two other prefectures, a cabinet minister said on Friday, as Japan struggles to contain a resurgent pandemic.Under a new state of emergency issu...

Wildlife spotted in Sao Paulo river after removal of tons of trash

Recent sightings of fish, ducks and herons in a stretch of the infamously polluted Pinheiros river in So Paulo have raised hopes that wildlife in the citys main waterway may finally be returning. Brazils most populous city has an ambitious ...

Saudi-led coalition intercepted a Houthi explosives-laden drone -state TV

The Saudi-Led coalition intercepted a Houthi explosives-laden drone fired at the kingdoms southern region, state TV reported early on Friday.A military coalition led by Saudi Arabia intervened in Yemen against the Houthis in 2015. The movem...

Japan says to seek 'short, powerful' state of emergency for Tokyo, Osaka and elsewhere

The Japanese government is seeking a short and powerful state of emergency for Tokyo, Osaka and two other prefectures, with restrictions to contain the coronavirus similar to those imposed last spring, a cabinet minister said on Friday. Und...

Give Feedback